NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
19 hedge funds and large institutions have $21.5M invested in Nexvet Biopharma plc Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$87K | |
| 2 | +$51.8K | |
| 3 | +$29K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$25K |
| 5 |
Citigroup
New York
|
+$18.1K |
Top Sellers
| 1 | -$539K | |
| 2 | -$298K | |
| 3 | -$18.2K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.35K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.41K |